Wikidata

(Q43593354)

English

Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody

scientific article published in March 2001

In more languages

Statements

title
Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11330541
retrieved
25 November 2017
author name string
Garrity ER Jr
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11330541
retrieved
25 November 2017
Villanueva J
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
11330541
retrieved
25 November 2017
Bhorade SM
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
11330541
retrieved
25 November 2017
Husain AN
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
11330541
retrieved
25 November 2017
Vigneswaran WT
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
11330541
retrieved
25 November 2017
publication date
1 March 2001
1 reference
stated in
Europe PubMed Central
PubMed ID
11330541
retrieved
25 November 2017
page(s)
773-777
1 reference
stated in
Europe PubMed Central
PubMed ID
11330541
retrieved
25 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43593354&oldid=2101757304"